ロード中...
Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers
Tropomyosin receptor kinase A, B and C (TRKA, TRKB and TRKC), which are well-known members of the cell surface receptor tyrosine kinase (RTK) family, are encoded by the neurotrophic receptor tyrosine kinase 1, 2 and 3 (NTRK1, NTRK2 and NTRK3) genes, respectively. TRKs can regulate cell proliferation...
保存先:
| 出版年: | Acta Pharm Sin B |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7893124/ https://ncbi.nlm.nih.gov/pubmed/33643817 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.apsb.2020.05.004 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|